Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Working Capital Changes (2016 - 2025)

Traws Pharma (TRAW) has disclosed Other Working Capital Changes for 14 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 1959.48% to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$690000.0, a 56.44% increase, with the full-year FY2024 number at -$226000.0, changed 0.0% from a year prior.
  • Other Working Capital Changes was $2.2 million for Q3 2025 at Traws Pharma, up from -$2.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $2.2 million in Q3 2025 to a low of -$2.0 million in Q2 2025.
  • A 5-year average of -$73000.0 and a median of -$56000.0 in 2021 define the central range for Other Working Capital Changes.
  • Biggest YoY gain for Other Working Capital Changes was 1959.48% in 2025; the steepest drop was 100950.0% in 2025.
  • Traws Pharma's Other Working Capital Changes stood at -$337000.0 in 2021, then skyrocketed by 218.4% to $399000.0 in 2022, then plummeted by 454.39% to -$1.4 million in 2023, then skyrocketed by 96.04% to -$56000.0 in 2024, then surged by 3951.79% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Other Working Capital Changes are $2.2 million (Q3 2025), -$2.0 million (Q2 2025), and -$774000.0 (Q1 2025).